• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Mayo Clin Proc Innov Qual Outcomes . Personalized Prediction of Hospital Mortality in COVID-19 positive patients

tetano

Editor, Senior Moderator
Mayo Clin Proc Innov Qual Outcomes


. 2021 May 12.
doi: 10.1016/j.mayocpiqo.2021.05.001. Online ahead of print.
Personalized Prediction of Hospital Mortality in COVID-19 positive patients


Daniel Rozenbaum[SUP] 1 [/SUP], Jacob Shreve[SUP] 1 [/SUP], Nathan Radakovich[SUP] 2 [/SUP], Abhijit Douggal[SUP] 3 [/SUP], Lara Jehi[SUP] 4 [/SUP], Aziz Nazha[SUP] 1 2 5 [/SUP]



Affiliations

Abstract

Objective: To develop predictive models for in-hospital mortality and length of stay (LOS) for COVID-19 positive patients.
Patients and methods: We performed a multicenter retrospective cohort study of hospitalized COVID-19 positive patients. A total of 764 patients admitted to 14 different hospitals within the Cleveland Clinic from 03/09/2020 to 05/20/2020 who had reverse transcriptase-polymerase chain reaction proven coronavirus infection were included. We used LightGBM, a machine learning algorithm, to predict in-hospital mortality at different time points (after 7 days, 14 days, and 30 days of hospitalization) and in-hospital LOS.
Results: Among 764 patients, 116 (15%) either died (n = 87) or were transitioned to hospice care (n = 29) during their hospitalization. The median LOS was 5 days (range 1 - 44 days) for patients admitted to the regular nursing floor and 10 days (range 1-38 days) for patients admitted to the intensive care unit (ICU). Patients who died during hospitalization were older, initially admitted to the ICU, more likely to be white and to have worse organ dysfunction compared to patients who survived their hospitalization. Using the 10 most important variables only, the final model's area under the Receiver Operating Characteristics curve was 0.86 for 7-day, 0.88 for 14-day, and 0.85 for 30-day mortality in the validation cohort.
Conclusions: We developed a decision tool that can provide explainable and patient-specific prediction of in-hospital mortality and LOS for COVID-19 positive patients. The model can aid healthcare systems in bed allocation and distribution of vital resources.

Keywords: COVID-19; COVID-19, Coronavirus disease 2019; ICU, Intensive care unit; LOS, Length of stay; Personalized prediction; ROC AUC, Area under the Receiver Operating Characteristics curve; mortality.



.
 
Back
Top Bottom